LON:NIPT Premaitha Health (NIPT) Share Price, News & Analysis GBX 9.10 +0.20 (+2.25%) (As of 11/6/2018) Add Compare Share Share Today's Range 9.10▼ 9.1050-Day Range 9.10▼ 9.1052-Week Range 3.78▼ 14.80Volume1.57 million shsAverage Volume1.35 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Premaitha Health alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About Premaitha Health Stock (LON:NIPT)Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.Read More NIPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NIPT Stock News HeadlinesJune 14, 2023 | forbes.comWeight Loss Diets And Workouts For Women To Try In 2023May 10, 2023 | marketwatch.comEurope Non Invasive Prenatal Testing Market Scope, Trends, Growth Status, Share, Revenue and Forecast 2023 to 2031July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 10, 2023 | marketwatch.comNon-Invasive Prenatal Testing Market Key Players, Revenue, Share, Future Trends, Growth and Forecast 2023 to 2031May 5, 2023 | marketwatch.comNon Invasive Prenatal Testing (NIPT) Market Size (2023 to 2030) New Study on Global Industry Trends and Forecast with Top Countries DataMarch 18, 2023 | finance.yahoo.comNon-Invasive Prenatal Testing (NIPT) Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast ReportMarch 9, 2023 | fool.co.ukPremaitha HealthFebruary 23, 2023 | uk.finance.yahoo.comNon-invasive Prenatal Testing Global Market Report 2023July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 19, 2023 | marketwatch.comNon-Invasive Prenatal Testing (NIPT) Market 2023: A Status of Top Regions and Companies with Growth ProspectsJuly 12, 2022 | marketwatch.comIndia Non-Invasive Prenatal Testing (NIPT) Market Size to reach 62 Million USD by 2022-2028March 6, 2022 | fool.co.ukPersimmon (LSE:PSN)November 10, 2021 | lse.co.ukPremaitha Health Share ChatSee More Headlines Receive NIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/29/2017Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Laboratories & Research Sub-IndustryN/A Current SymbolLON:NIPT Previous SymbolLON:VIY CUSIPN/A CIKN/A Webwww.premaitha.com Phone+44-161-6676865FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Stephen Little (Age 61)Exec. Vice Chairman Mr. Barry HextallCFO, Sec. & Exec. DirectorMr. Peter Collins (Age 59)Chief Bus. Officer & Exec. Director Mr. Lyn Fafydd Rees (Age 45)CEO & Director Dr. Chia-Han Chan (Age 42)Chief Scientific Officer & Director Key CompetitorsAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNSinclair PharmaLON:SPHSummit TherapeuticsLON:SUMMView All Competitors NIPT Stock Analysis - Frequently Asked Questions How have NIPT shares performed this year? Premaitha Health's stock was trading at GBX 9.10 at the start of the year. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10. View the best growth stocks for 2024 here. How were Premaitha Health's earnings last quarter? Premaitha Health PLC (LON:NIPT) announced its earnings results on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The firm had revenue of $2.71 million for the quarter. How do I buy shares of Premaitha Health? Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Premaitha Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO) and Scancell (SCLP). This page (LON:NIPT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premaitha Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Premaitha Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.